RNS Number : 9504J
BP PLC
02 December 2025
 

BP p.l.c.

 

Transaction in Own Shares

 

BP p.l.c. (the "Company") announces that on 02 December 2025 it has purchased, in accordance with the authority granted by shareholders at the 2025 Annual General Meeting of the Company, a total of 1,495,036 of its ordinary shares of $0.25 each ("Shares") on the London Stock Exchange and Cboe (UK) as part of the buyback programme announced on 4 November 2025 (the "Programme") and as detailed below:

 


London Stock Exchange

Cboe (UK)/BXE

Cboe (UK)/CXE

Number of Shares purchased:

1,043,599

98,881

352,556

Highest price paid per Share (pence):

461.70

461.70

461.70

Lowest price paid per Share (pence):

456.25

456.25

456.25

Volume weighted average price paid per Share (pence):

459.2412

459.2032

459.3731

 

The Company intends to transfer these shares into Treasury in accordance with the authority granted by its shareholders at the Company's 2025 Annual General Meeting.

 

Following the above purchase of Shares, the Company will hold 838,644,900 ordinary shares in treasury and have 15,647,668,094 ordinary shares and 12,706,252 preference shares in issue (excluding Treasury shares).

 

The schedule below contains detailed information about the purchases made by Morgan Stanley and Co. International p.l.c. (intermediary code: MSLNGB2X) on the date of purchase as part of the Programme.

 

Further enquiries:

bp Investor Relations     +44(0) 207 496 4000

 

Schedule of Purchases

 

Shares purchased: BP p.l.c. (ISIN CODE: GB0007980591)

 

Aggregate information:

 

Venue

Volume-weighted

average price (pence)

Aggregated volume

London Stock Exchange

459.2412

1,043,599

Cboe (UK)/BXE

459.2032

98,881

Cboe (UK)/CXE

459.3731

352,556

 

Individual transactions:

 

To view details of the individual transactions, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/9504J_1-2025-12-2.pdf

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUUVNRVNUURAA